• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acylaminobenzoic acid and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Acylaminobenzoic acid and derivatives

Methyl 4-acetamido-3-bromobenzoate (CAS No. 126759-47-5): A Comprehensive Overview

Methyl 4-acetamido-3-bromobenzoate, with the chemical formula C₉H₈BrNO₄, is a significant compound in the field of pharmaceutical and biochemical research. This compound, identified by its unique CAS number 126759-47-5, has garnered attention due to its versatile applications in drug development and synthetic chemistry. The presence of both bromine and acetamido functional groups makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the realm of medicinal chemistry.

The structural characteristics of Methyl 4-acetamido-3-bromobenzoate contribute to its utility in various chemical transformations. The bromine atom at the 3-position provides a reactive site for cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing biaryl systems. These systems are frequently found in biologically active compounds, including many pharmaceuticals. Additionally, the acetamido group at the 4-position can serve as a protecting group or a site for further functionalization, enhancing the compound's adaptability in synthetic pathways.

In recent years, Methyl 4-acetamido-3-bromobenzoate has been explored in the development of novel therapeutic agents. Its structural framework is reminiscent of several known bioactive molecules, suggesting potential applications in the treatment of various diseases. For instance, researchers have investigated its role in designing inhibitors targeting specific enzymatic pathways. These pathways are often implicated in inflammatory responses, cancer, and infectious diseases. The compound's ability to undergo selective modifications makes it an attractive candidate for structure-activity relationship (SAR) studies.

One notable application of Methyl 4-acetamido-3-bromobenzoate is in the synthesis of small-molecule inhibitors designed to modulate protein-protein interactions. Such interactions are critical in many biological processes and are often disrupted in disease states. By targeting these interactions with tailored inhibitors, researchers aim to develop treatments that can restore normal cellular function. The bromine and acetamido groups provide multiple handles for chemical modification, allowing for the precise tuning of inhibitor properties such as binding affinity and selectivity.

The compound's significance extends beyond its role as a synthetic intermediate. It has also been utilized in the development of probes for biochemical assays. These probes are essential tools for understanding enzyme mechanisms and identifying new drug targets. The unique reactivity of Methyl 4-acetamido-3-bromobenzoate allows it to be incorporated into probe molecules that can report on specific biochemical events within cells. This capability is particularly valuable in high-throughput screening campaigns aimed at discovering new therapeutic leads.

Recent advancements in synthetic methodologies have further highlighted the utility of Methyl 4-acetamido-3-bromobenzoate. For example, transition-metal-catalyzed reactions have enabled more efficient and selective transformations of this compound. These methods have reduced reaction times and improved yields, making it more feasible to incorporate Methyl 4-acetamido-3-bromobenzoate into complex synthetic schemes. Such improvements are crucial for accelerating drug discovery pipelines and bringing new therapies to market more rapidly.

The growing interest in green chemistry has also influenced the use of Methyl 4-acetamido-3-bromobenzoate. Researchers are increasingly seeking to develop synthetic routes that minimize waste and reduce environmental impact. The compound's versatility allows it to be employed in such sustainable approaches, contributing to more environmentally friendly pharmaceutical synthesis. This aligns with broader efforts within the industry to adopt greener practices and reduce the ecological footprint of drug production.

In conclusion, Methyl 4-acetamido-3-bromobenzoate (CAS No. 126759-47-5) is a multifaceted compound with significant applications in pharmaceutical research and development. Its unique structural features make it a valuable intermediate for constructing complex molecules, particularly those targeting disease-related biological pathways. The ongoing exploration of its potential applications underscores its importance as a tool in modern medicinal chemistry. As synthetic methodologies continue to evolve, the utility of this compound is expected to expand further, driving innovation in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)